System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Juan Carlos Cardet is an expert in Immunology at University of South Florida (United States). As of September 2026, ScienceLeadR ranks Juan Carlos Cardet in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Juan Carlos Cardet has authored 90 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 1 of them ongoing. SLR score: 631 (community average: 125). How the SLR is computed.

LeadR Profile

Juan Carlos Cardet University of South Florida United States
631 ScienceLeadR Reputation 631

Unlock

Register Login
Network Map

Immunology

Subspecialties: Pulmonology - Public Health - Allergy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026
Source: PubMed

University of South Florida

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 90

Citations

Citations: 3 047 1st author: 29 Last author: 19 Unique author: 1

Main journals

J Allergy Clin Immunol 27
J Allergy Clin Immunol Pract 17
Am J Respir Crit Care Med 7
Ann Allergy Asthma Immunol 5
N Engl J Med 4

Best Journals

N Engl J Med 4
Am J Respir Crit Care Med 1
JAMA 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies.
PMID 42747714 — epidemiology, hypersensitivity, therapeutics, asthma		Curr Allergy Asthma Rep20260
Recommended Vaccines for Immunocompetent Older Adults: Work Group Report of the AAAAI Allergy and Asthma in Older Adults Committee.
PMID 41823941 — vaccines, hypersensitivity, vaccination, work, viruses, centers for disease control and prevention, u.s., asthma, communicable diseases, allergy		J Allergy Clin Immunol Pract20262
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline Cohort.
PMID 41707916 — multiple chronic conditions, eosinophils, biomarkers, diagnosis, asthma		J Allergy Clin Immunol20260
Inhaled corticosteroid (ICS) adherence after exacerbations: Transient gains without lasting benefits.
PMID 41638776 — hypersensitivity, adrenal cortex hormones, immunity, asthma		Ann Allergy Asthma Immunol20260
Primary care provider referral patterns and awareness of biologic therapy for uncontrolled asthma.
PMID 41542136 — laboratories, adrenal cortex hormones, biomarkers, antibodies, monoclonal, therapeutics, asthma, biological therapy		J Allergy Clin Immunol Glob20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Director: 1

By phase:

N/A 3
Phase 3 3
Phase 2 1
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 8
Recruiting 1

By type:

Interventional 7
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
NCT07396987 — emergencies, adrenal cortex hormones, telemedicine, muscarinic antagonists, prescriptions, aftercare, signs and symptoms, medication adherence, therapeutics, asthma, emergency service, hospital, social determinants of health		N/ARecruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS